0000000000624481

AUTHOR

Müller-klieser W

showing 3 related works from this author

Effect of hyperthermia on tumor blood flow.

1984

Differences in blood perfusion rates between tumors and normal tissue can be utilized to selectively heat many solid tumors. Blood flow in normal tissues is considerably increased at temperatures commonly applied during localized hyperthermia. In contrast, tumor blood flow may respond to localized heat typically in two different blood flow patterns: Flow may either decrease continuously with increasing exposure time and/or temperature or flow may exhibit a transient increase followed by a decline. A decrease in blood flow at high thermal doses can be observed in most of the tumors, whereas an increase in flow at low thermal doses seems to occur less frequently. The inhibition of blood flow …

Hyperthermiamedicine.medical_specialtyHot TemperatureTime FactorsPhysiologyChemistryMicrocirculationNormal tissueBlood flowNeoplasms Experimentalmedicine.diseaseRatsMiceCell killingEndocrinologyTreatment modalityRegional Blood FlowPhysiology (medical)Internal medicineCancer cellmedicineAnimalsIrradiationPerfusionBlood Flow VelocityBiorheology
researchProduct

Hemodilution in isolated tumor perfusion.

1984

Experiments are performed to study the influence of local hemodilution on tumor blood flow, oxygen availability in tumor tissue and O2 consumption of cancer cells. The results obtained clearly show that hemodilution in isolated tumor perfusion can distinctly improve nutritive blood flow through solid tumors. This can be utilized to enhance pharmacokinetics of antitumor drugs. Due to the improved metabolic status, the pharmacodynamics of some antitumor drugs should also be enhanced. To achieve a maximum improvement of the O2 supply to the tumor, hematocrit values should not be decreased below 0.20.

PhysiologyPharmacologyHematocritMicrocirculationOxygen ConsumptionPharmacokineticsCarcinosarcomaPhysiology (medical)CarcinosarcomamedicineAnimalsHemodilutionmedicine.diagnostic_testbusiness.industryMicrocirculationRats Inbred StrainsBlood flowmedicine.diseaseKidney NeoplasmsRatsmedicine.anatomical_structureHematocritRegional Blood FlowPharmacodynamicsCancer cellVascular resistanceVascular ResistancebusinessBlood Flow VelocityBiorheology
researchProduct

Cytostatic Activity of Aeroplysinin-1 against Lymphoma and Epithelioma Cells

1989

(±)-Aeroplysinin-1, an optically active 1.2-dihydroarene-1.2-diol. was isolated from the marine sponges Verongia aerophoba (+-isomer) and lanthella ardis (--isomer). For the experiments presented we used the +-isomer from Verongia aerophoba. Here we describe the hitherto unknown biological and pharmacological property of this compound to display pronounced anticancer activity against L5178y mouse lymphoma cells (ED50: 0.5 μm). Friend erythroleukemia cells (ED50: 0.7μm) , human mamma carcinoma cells (ED50: 0.3μm) and human colon carcinoma cells (ED50: 3.0 μm) in vitro. Furthermore, aeroplysinin caused a preferential inhibition of [3H]thymidine (dThd) incorporation rates in L5178y mouse lymph…

MaleSalmonella typhimuriumAcetonitrilesCell SurvivalCellAntineoplastic AgentsMice Inbred StrainsBiologyGeneral Biochemistry Genetics and Molecular BiologyCell LineMicechemistry.chemical_compoundIn vivoCyclohexenesTumor Cells CulturedmedicineCarcinomaAnimalsHumansLeukemia L5178ED50Leukemia ExperimentalMutagenicity TestsMelanomaCarcinomamedicine.diseaseVirologyMolecular biologyIn vitroLymphomamedicine.anatomical_structurechemistryDrug Screening Assays AntitumorThymidineZeitschrift für Naturforschung C
researchProduct